Literature DB >> 10695770

Chronic fatigue syndrome and/or fibromyalgia as a variation of antiphospholipid antibody syndrome: an explanatory model and approach to laboratory diagnosis.

D Berg1, L H Berg, J Couvaras, H Harrison.   

Abstract

Chronic Fatigue and/or Fibromyalgia have long been diseases without definition. An explanatory model of coagulation activation has been demonstrated through use of the ISAC panel of five tests, including, Fibrinogen, Prothrombin Fragment 1+2, Thrombin/ AntiThrombin Complexes, Soluble Fibrin Monomer, and Platelet Activation by flow cytometry. These tests show low level coagulation activation from immunoglobulins (Igs) as demonstrated by Anti-B2GPI antibodies, which allows classification of these diseases as a type of antiphospholipid antibody syndrome. The ISAC panel allows testing for diagnosis as well as monitoring for anticoagulation protocols in these patients.

Entities:  

Mesh:

Year:  1999        PMID: 10695770     DOI: 10.1097/00001721-199910000-00006

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  10 in total

1.  Connective tissue: Vascular and hematological (blood) support.

Authors:  Nick Calvino
Journal:  J Chiropr Med       Date:  2003

2.  Post-Exertional Malaise in Patients with ME and CFS with Comorbid Fibromyalgia.

Authors:  Stephanie L McManimen; Leonard A Jason
Journal:  SRL Neurol Neurosurg       Date:  2017-03-10

3.  Chronic Fatigue Exhibits Heterogeneous Autoimmunity Characteristics Which Reflect Etiology.

Authors:  Olga V Danilenko; Natalia Y Gavrilova; Leonid P Churilov
Journal:  Pathophysiology       Date:  2022-05-25

4.  Enhanced antithrombotic effects of unfractionated heparin in rats after repeated oral doses and its relationship to endothelial heparin concentration.

Authors:  L M Hiebert; T Ping; S M Wice
Journal:  Br J Pharmacol       Date:  2008-02-11       Impact factor: 8.739

5.  Significant correlation between plasma proteome profile and pain intensity, sensitivity, and psychological distress in women with fibromyalgia.

Authors:  Karin Wåhlén; Malin Ernberg; Eva Kosek; Kaisa Mannerkorpi; Björn Gerdle; Bijar Ghafouri
Journal:  Sci Rep       Date:  2020-07-27       Impact factor: 4.379

6.  A Molecular network approach reveals shared cellular and molecular signatures between chronic fatigue syndrome and other fatiguing illnesses.

Authors:  Phillip H Comella; Edgar Gonzalez-Kozlova; Roman Kosoy; Alexander W Charney; Irene Font Peradejordi; Shreya Chandrasekar; Scott R Tyler; Wenhui Wang; Bojan Losic; Jun Zhu; Gabriel E Hoffman; Seunghee Kim-Schulze; Jingjing Qi; Manishkumar Patel; Andrew Kasarskis; Mayte Suarez-Farinas; Zeynep H Gümüş; Carmen Argmann; Miriam Merad; Christian Becker; Noam D Beckmann; Eric E Schadt
Journal:  medRxiv       Date:  2021-02-02

7.  Lessons From Heat Stroke for Understanding Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors:  Dominic Stanculescu; Nuno Sepúlveda; Chin Leong Lim; Jonas Bergquist
Journal:  Front Neurol       Date:  2021-12-13       Impact factor: 4.003

Review 8.  A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications.

Authors:  Douglas B Kell; Gert Jacobus Laubscher; Etheresia Pretorius
Journal:  Biochem J       Date:  2022-02-17       Impact factor: 3.857

9.  The Occurrence of Hyperactivated Platelets and Fibrinaloid Microclots in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Authors:  Jean M Nunes; Arneaux Kruger; Amy Proal; Douglas B Kell; Etheresia Pretorius
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-27

Review 10.  The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications.

Authors:  Douglas B Kell; Etheresia Pretorius
Journal:  Biochem J       Date:  2022-08-31       Impact factor: 3.766

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.